Nipro PharmaPackaging is specialized in developing and manufacturing advanced pharma packaging products and complete packaging solutions for early development drugs or the enhancement of packaging solutions for existing drugs. Nipro PharmaPackaging is part of Nipro Corporation Japan, established in 1954. As a leading global healthcare com

Knowledge Boost: Learn latest mRNA trends, AI cold chain tech, and BioE3 rules from top vaccine experts and regulators.
Network with Leaders: Connect directly with C-suite execs, QA heads, and CDSCO officials from pharma giants.
Future-Proof Your Role: Discover investment opportunities, clinical trial innovations, and resilient
networks for One Health and pandemic prep.
Strategic Insights: Get practical takeaways on scaling production, fighting hesitancy, and global export strategies for India's USD 3B
market.
Solve Real Challenges : Assess cold chain gaps, GMP compliance risks, and supply disruptions with actionable Industry 4.0 solutions.

We are delighted to announce the 5th Edition of India Vaccine Leaders Conclave 2026 which is going to be held in Pune during 20th & 21st August 2026, Hyatt, Pune. The IVLC strives to provide a meaningful theme of “India’s Bio-Ascent: Redefining Global Vaccine Value” & will assemble leading specialists from around the world including researchers, scientists, academicians, vaccinologists, immunologists, healthcare professionals, clinicians, government representatives & industry delegates who will share their knowledge on the field’s most recent ground-breaking advancements & discoveries & Collaborations.

India's vaccine industry, the world's third largest by volume, is targeting over USD 3 billion in 2026, driven by biosimilars, government UIP expansions, and BioE3 policies boosting local production.
Globally, the market reaches USD 67-96 billion this year with 6-10% growth fuelled by mRNA vaccines for adults and pandemic readiness. Include AI-powered cold chains for better storage, faster manufacturing via PLI funds for APIs, and efforts to cut hesitancy through awareness and compensation schemes. Despite factory and regulatory hurdles, these steps position India as a key player amid rising demand for multi-disease shots.
BlueTech Media LLP
310, 3rd floor, Banarsi Heritage Office, Malad, Ram Nagar, Malad West, Mumbai, Maharashtra, India
Copyright © 2026 BlueTech Media LLP - All Rights Reserved.
Designed by Whyte Wings Media